Therapeutic efficacy of infused molecular hydrogen in saline on rheumatoid arthritis: A randomized, double-blind, placebo-controlled pilot study

International Immunopharmacology ◽

10.1016/j.intimp.2014.06.001 ◽

2014 ◽

Vol 21 (2) ◽

pp. 468-473 ◽

Author(s):

Toru Ishibashi ◽

Bunpei Sato ◽

Shinji Shibata ◽

Takaaki Sakai ◽

Yuichi Hara ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Pilot Study ◽

Therapeutic Efficacy ◽

Molecular Hydrogen ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Intra-articular Administration of Polyclonal Immunoglobulin G in Rheumatoid Arthritis: A double-blind, placebo-controlled pilot study

Scandinavian Journal of Rheumatology ◽

10.3109/03009749609080010 ◽

1996 ◽

Vol 25 (3) ◽

pp. 174-176 ◽

Author(s):

E. Bagge ◽

M. Geijer ◽

A. Tarkowski

Keyword(s):

Rheumatoid Arthritis ◽

Pilot Study ◽

Immunoglobulin G ◽

Double Blind ◽

Double Blind Placebo ◽

Polyclonal Immunoglobulin

Download Full-text

Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70008-7 ◽

2007 ◽

Vol 2007 ◽

pp. 11-12 ◽

Author(s):

D.L. Kimpel

Keyword(s):

Rheumatoid Arthritis ◽

Therapeutic Efficacy ◽

Randomised Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Download Full-text

Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal

Case Medical Research ◽

10.31525/ct1-nct04070157 ◽

2019 ◽

Author(s):

Keyword(s):

Pilot Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1047881.502548 ◽

2006 ◽

Author(s):

Paul-Peter Tak

Keyword(s):

Rheumatoid Arthritis ◽

Therapeutic Efficacy ◽

Randomised Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Download Full-text

Faculty Opinions recommendation of Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108512.564581 ◽

2008 ◽

Author(s):

Johanne Martel-Pelletier ◽

Jean-Pierre Raynauld

Keyword(s):

Rheumatoid Arthritis ◽

Interleukin 6 ◽

Randomised Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Receptor Inhibition ◽

Interleukin 6 Receptor

Download Full-text

Faculty Opinions recommendation of The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1164186.624873 ◽

2009 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Jak Inhibitor ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1168312.630474 ◽

2009 ◽

Author(s):

Robert Findling

Keyword(s):

Bipolar Disorder ◽

Pilot Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1229980.697084 ◽

2009 ◽

Author(s):

Martin Aringer ◽

Alexander Kleymann

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13349966.14726746 ◽

2011 ◽

Author(s):

Shafiqul A Sarker

Keyword(s):

Pilot Study ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13349966.14721054 ◽

2011 ◽

Author(s):

Reto Nüesch

Keyword(s):

Pilot Study ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Double Blind ◽

Double Blind Placebo

Download Full-text